MAP2K1 and cancer: Previous studies demonstrated that CRAF-MEK1/2-ERK1/2 signaling plays a crucial role in the regulation of EMT as well as cell migration and invasion in several cancers (Birchmeier et al., 1993; Hay and Zuk, 1995; Schoenenberger et al., 1991).